I sure hope something is in the wind perhaps with PBT2 in light of Eli Lilly's positive news yesterday regarding their ALTZ drug. For over 20 years I have felt that Lilly would be be best company for Prana/ Alterity to partner with or be bought out by. I also recall that back then, Prana had some sort of relationship with Lilly but now the players at Lilly especially have no doubt changed. It sure would behoove Dr.Stamler, Mr. Kempler, and especially Professor Masters to contact some key players at Eli Lilly to congratulate them on their success so far and, at the same time, remind them and/or clue them in about our recent successes with both PBT2, ATH434, and the newly discovered small molecule platform drugs that we may be excited about. Be proactive for a change and take the bull by the horns, men!
ATH Price at posting:
0.7¢ Sentiment: Hold Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)